Accenture has recently announced a strategic investment in 1910 Genetics, a Boston-based biotechnology company that specializes in integrating artificial intelligence (AI) and biological automation to expedite drug discovery processes. This investment is part of Accenture Ventures’ ongoing commitment to foster innovation in the life sciences sector, especially in collaboration with emerging biotech companies. Accenture aims […]
Accenture Ventures has announced an investment in Earli Inc., a pioneering biotechnology firm based in Redwood City, California. This investment is poised to revolutionize early cancer detection through Earli’s innovative synthetic targeting platform, which selectively reprograms cancer cells to reveal and destroy themselves. This strategic move aims to enhance collaborations with global health and pharmaceutical […]
